Masimo Corporation (MASI)
- Previous Close
135.92 - Open
136.35 - Bid 135.65 x 100
- Ask 136.40 x 100
- Day's Range
135.53 - 137.44 - 52 Week Range
75.22 - 198.00 - Volume
50,503 - Avg. Volume
544,933 - Market Cap (intraday)
7.192B - Beta (5Y Monthly) 0.98
- PE Ratio (TTM)
90.01 - EPS (TTM)
1.51 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Nov 23, 2012
- 1y Target Est
150.03
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
www.masimo.comRecent News: MASI
Performance Overview: MASI
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MASI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MASI
Valuation Measures
Market Cap
7.19B
Enterprise Value
8.00B
Trailing P/E
90.01
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.59
Price/Book (mrq)
5.27
Enterprise Value/Revenue
3.91
Enterprise Value/EBITDA
33.79
Financial Highlights
Profitability and Income Statement
Profit Margin
3.98%
Return on Assets (ttm)
2.93%
Return on Equity (ttm)
6.03%
Revenue (ttm)
2.05B
Net Income Avi to Common (ttm)
81.5M
Diluted EPS (ttm)
1.51
Balance Sheet and Cash Flow
Total Cash (mrq)
163M
Total Debt/Equity (mrq)
71.07%
Levered Free Cash Flow (ttm)
31.65M
Research Analysis: MASI
Analyst Price Targets
Fair Value
Analyst Recommendations
Earnings
Research Reports: MASI
MASI: Lowering target price to $145.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $145.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMASI: Raising target price to $152.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $152.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMASI: Lowering target price to $147.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $147.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice TargetMASI: Raising target price to $148.00
MASIMO CORP has an Investment Rating of HOLD; a target price of $148.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
RatingNeutralPrice Target